+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global AI in Diagnostics Market (2021-2026) by Components, Diagnosis and Geography - Competitive Analysis, Impact of COVID-19, Ansoff Analysis

  • PDF Icon

    Report

  • 190 Pages
  • March 2021
  • Region: Global
  • Infogence Global Research
  • ID: 5359457

The Global AI in Diagnostics Market is estimated to be worth USD 1,125 Million in 2021 and is expected to reach USD 3,790 Million by 2026, growing at a CAGR of 27.5%.




Market Dynamics

Growing demand for low-cost diagnostic techniques, effective and efficient report analysis and quick diagnostic data generation are expected to drive the market in the forecast period. Improving computing power and declining hardware cost is further expected to boost the market. Growing demand for reducing diagnostic costs, improving patient care, and reducing machine downtime is expected to increase the application of AI in diagnostics.

Lack of skilled AI workforce and ambiguous regulatory guidelines for medical software and high cost of implementation of AI solutions is expected to hinder the growth of the market.

Increasing partnerships and collaborations between various AI service providers and advancements in Deep Learning and AI have created lucrative opportunities for the growth of the market.

Concerns regarding data privacy and lack of interoperability between AI solutions offered by different vendors are big challenges in front of the industry players.


Market Segmentation

The Global Artificial Intelligence in Diagnostics Market is segmented based on Components, Diagnosis, and Geography.


  • By Components, the market is classified into Services, Software and Hardware. Software segment to hold the largest share in AI in diagnostics market.
  • By Diagnosis, the market is classified into Radiology, Oncology, Neurology, Cardiology, Chest & Lungs, Pathology and Other Diagnosis Types
  • By Geography, North America holds major share of artificial intelligence in diagnostics market.

Recent Developments


  1. In March 2020, IBM Watson Health and EBSCO Information Services partnered to provide access to evidence-based drug and disease information that can help support clinicians and individuals as they cope with infectious diseases, including COVID-19.
  2. Jun-2020: GE Healthcare announced collaboration with Lunit, a South Korean startup. Together with Lunit, GE launched an artificial intelligence-powered chest X-ray analysis suite. The suite has been designed to spot and highlight eight common conditions, using algorithms built by Lunit.
  3. Jul-2020: AliveCor introduced KardiaCare, a digital health subscription service. The service provides members the control and convenience of managing heart health at home. This new service delivers exclusive digital tools to make it easier for users to interpret their heart data, monitor risk factors, identify symptom triggers, and measure the impact of positive lifestyle changes as part of a long-term heart care program.

Company Profiles

Some of the companies covered in this report are NVIDIA Corporation, Intel Corporation, IBM Corporation, Google, Microsoft Corporation, Amazon Web Services, General Vision, Inc., GE Healthcare, Siemens Healthineers, Medtronic plc, Johnson & Johnson Inc, and Koninklijke Philips N.V. etc.


Competitive Quadrant

The report includes the Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.


Why buy this report?

The report offers a comprehensive evaluation of the Global Artificial Intelligence In Diagnostics Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.

The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel within the industry.

The report includes in-depth market analysis using Porter’s 5 force model and the Ansoff Matrix. The impact of COVID-19 on the market is also featured in the report.

The report also contains the competitive analysis using the Competitive Quadrant, the analyst's proprietary competitive positioning tool.


Report Highlights

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.3 Market Size Estimation
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
4 Market Overview
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Growing demand for low-cost diagnostic techniques, effective and efficient report analysis, and quick diagnostic data generation
4.2.1.2 Improving computing power and declining hardware cost
4.2.1.3 Growing demand for reducing diagnostic costs, improving patient care, and reducing machine downtime
4.2.2 Restraints
4.2.2.1 Lack of skilled AI workforce and ambiguous regulatory guidelines for medical software
4.2.2.2 High cost of implementation
4.2.3 Opportunities
4.2.3.1 Increasing partnerships and collaborations between various AI service providers
4.2.3.2 Advancements in Deep Learning and AI
4.2.4 Challenges
4.2.4.1 Concerns regarding data privacy
4.2.4.2 Lack of interoperability between AI solutions offered by different vendors
4.3 Trends
5 Market Analysis
5.1 Porter’s Five Forces Analysis
5.2 Impact of COVID-19
5.3 Ansoff Matrix Analysis
6 Global Artificial Intelligence In Diagnostics Market, By Components
6.1 Introduction
6.2 Hardware
6.3 Software
6.4 Services
7 Global Artificial Intelligence In Diagnostics Market, By Diagnosis
7.1 Introduction
7.2 Radiology
7.3 Pathology
7.4 Cardiology
7.5 Oncology
7.6 Neurology
7.7 Chest and Lung
7.8 Others
8 Global Artificial Intelligence In Diagnostics Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 South America
8.3.1 Brazil
8.3.2 Argentina
8.4 Europe
8.4.1 UK
8.4.2 France
8.4.3 Germany
8.4.4 Italy
8.4.5 Spain
8.4.6 Rest of Europe
8.5 Asia-Pacific
8.5.1 China
8.5.2 Japan
8.5.3 India
8.5.4 Indonesia
8.5.5 Malaysia
8.5.6 South Korea
8.5.7 Australia
8.5.8 Russia
8.5.9 Rest of APAC
8.6 Rest of the World
8.6.1 Qatar
8.6.2 Saudi Arabia
8.6.3 South Africa
8.6.4 United Arab Emirates
8.6.5 Latin America
9 Competitive Landscape
9.1 Competitive Quadrant
9.2 Market Share Analysis
9.3 Competitive Scenario
9.3.1 Mergers & Acquisitions
9.3.2 Agreement, Collaborations, & Partnerships
9.3.3 New Product Launches & Enhancements
9.3.4 Investments & Funding
10 Company Profiles
10.1 AIndra
10.2 Amazon Web Services, Inc.
10.3 Atomwise, Inc.
10.4 Babylon Health
10.5 Butterfly Network Inc.
10.6 Caption Health
10.7 Caresyntax Inc.
10.8 Cloudmedx Inc.
10.9 Context Vision
10.10 Cota Healthcare
10.11 CureMetrix Inc.
10.12 Enlitic, Inc.
10.13 FDNA, Inc.
10.14 GE Healthcare
10.15 Google LLC
10.16 IBM Corporation
10.17 Imagia Cybernetics Inc.
10.18 Intel Corporation
10.19 Johnson & Johnson
10.20 Koninklijke Philips N.V.
10.21 Linguamatics (UK)
10.22 Lucina Health Inc.
10.23 Lunit Inc.
10.24 MDLIVE Inc.
10.25 Medtronic Plc.
10.26 Micron Technologies
10.27 Microsoft Corporation
10.28 NVIDIA Corporation
10.29 Physiq, Inc.
10.30 Qure.ai Technologies Private Limited
10.31 Siemens Healthineers AG
11 Appendix
11.1 Questionnaire

Companies Mentioned

  • AIndra
  • Amazon Web Service. Inc.
  • Atomwis. Inc.
  • Babylon Health
  • Butterfly Network Inc.
  • Caption Health
  • Caresyntax Inc.
  • Cloudmedx Inc.
  • Context Vision
  • Cota Healthcare
  • CureMetrix Inc.
  • Enliti. Inc.
  • FDN. Inc.
  • GE Healthcare
  • Google LLC
  • IBM Corporation
  • Imagia Cybernetics Inc.
  • Intel Corporation
  • Johnson & Johnson
  • Koninklijke Philips N.V.
  • Linguamatics (UK)
  • Lucina Health Inc.
  • Lunit Inc.
  • MDLIVE Inc.
  • Medtronic PLC.
  • Micron Technologies
  • Microsoft Corporation
  • NVIDIA Corporation
  • Physi. Inc.
  • Qure.ai Technologies Private Limited
  • Siemens Healthineers AG

Table Information